Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q527H0

Entry ID Method Resolution Chain Position Source
AF-Q527H0-F1 Predicted AlphaFoldDB

No variants for Q527H0

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q527H0

1 associated diseases with Q527H0

[MIM: 248250]: Hypomagnesemia 3 (HOMG3)

A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis. Recurrent urinary tract infections and kidney stones are often observed. In spite of hypercalciuria, patients do not show hypocalcemia. {ECO:0000269|PubMed:10390358, ECO:0000269|PubMed:10878661, ECO:0000269|PubMed:11518780}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis. Recurrent urinary tract infections and kidney stones are often observed. In spite of hypercalciuria, patients do not show hypocalcemia. {ECO:0000269|PubMed:10390358, ECO:0000269|PubMed:10878661, ECO:0000269|PubMed:11518780}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for Q527H0

Type Name Position InterPro Accession
domain FAD linked oxidase, N-terminal 72 - 216 IPR006094
domain Cytokinin dehydrogenase 1, FAD/cytokinin binding domain 249 - 526 IPR015345
domain FAD-binding domain, PCMH-type 68 - 248 IPR016166

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
Prp19 complex A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
U2-type catalytic step 1 spliceosome A spliceosomal complex that is formed by the displacement of the U1 and U4 snRNPs from the precatalytic spliceosome; the U2, U5 and U6 snRNPs remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the U2, and U5 and U6 snRNPs.
U2-type catalytic step 2 spliceosome A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs.
U2-type post-mRNA release spliceosomal complex A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and the U2, U5 and U6 snRNPs.
U2-type prespliceosome A spliceosomal complex that is formed by association of the 5' splice site with the U1 snRNP, while the branch point sequence is recognized by the U2 snRNP. The prespliceosome includes many proteins in addition to those found in the U1 and U2 snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation.

2 GO annotations of molecular function

Name Definition
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA replication origin binding Binding to a DNA replication origin, a unique DNA sequence of a replicon at which DNA replication is initiated and proceeds bidirectionally or unidirectionally.

2 GO annotations of biological process

Name Definition
cis assembly of pre-catalytic spliceosome Assembly of a spliceosomal complex containing the intact pre-mRNA and all of the spliceosomal snRNPs. This occurs when the tri-snRNP associates with the pre-mRNA and associated snRNPs in an ATP-dependent manner.
DNA replication initiation The process in which DNA-dependent DNA replication is started; this begins with the ATP dependent loading of an initiator complex onto the DNA, this is followed by DNA melting and helicase activity. In bacteria, the gene products that enable the helicase activity are loaded after the initial melting and in archaea and eukaryotes, the gene products that enable the helicase activity are inactive when they are loaded and subsequently activate.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MEASRGPPRV KNKAAAPVQI SAEQLLREAT DRQEEALQKP TQRFEDLEEL HEYQGRKRKE
70 80 90 100 110 120
FESYCQRSGF NLKNWLQYAQ WELEQKEYAR SRSVFERALN LHANKVTLWI RYVEAELKSR
130 140 150 160 170 180
NINFARNLLD RAVTHLPRVD KLWYKYVWVE EMLGNIPGVR QVFERWMEWQ PDEAAWSAFI
190 200 210 220 230 240
KLEQRYGEYD RAREIFTRFT MVHPEPRNWI KWSKFEEEYG TSDRVREVFE RAIEELSKYG
250 260 270 280 290 300
DEFVEERLFI AYARYEAKLH DLDRARAIYK FGLENLPRSK AMLLHKEYTT FEKQYGDREG
310 320 330 340 350 360
VEDVVLSKRR RHYEDLVREN PKNYDVWFDY ARLEEASGDI DRTREVYEKA IAQVPPTQAK
370 380 390 400 410 420
RHWRRYIYLW IFFALWEETE AKNPERARQV YDTCLKLIPH RTFTFAKVWM HKAHFEIRQG
430 440 450 460 470 480
DLAAARKTLG RAIGMCPKDR LFKGYIEMEQ KLYEFGRCRI LYEKHIAYNP ANCSTWVKWA
490 500 510 520 530 540
ELERGLDDLD RARAILDMGI AQPVLDMPEV VWKSYIDFEE EEGEYDKTRS LYERLLDKAD
550 560 570 580 590 600
HPKVWISYAQ FEINIPEEAG EGADEEQEQP VSDEAKARAR RVFERAHQGF KDKEMKAERV
610 620 630 640 650 660
SILNAWLVFE KTHGSAEDIE KIEKQMPRRT KKKRKLDDDT WEEYVDYIFP ADEQVGKNLM
670 680 690
NMMAKARARK QAEAEAAAKA AAADDGGESG E